|
US6083922A
(en)
*
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
|
US6076520A
(en)
*
|
1997-05-12 |
2000-06-20 |
Cooper; Emily L. |
Device for nasal therapeutic inhalation
|
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
|
TW465235B
(en)
|
1998-09-17 |
2001-11-21 |
United Video Properties Inc |
Electronic program guide with digital storage
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
SI20959A
(sl)
*
|
1998-12-17 |
2003-02-28 |
Pathogenesis Corporation |
Metoda za zdravljenje hudega kroničnega bronhitisa (bronhiektazije) z aerosoliziranimi antibiotiki
|
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
|
WO2001058514A1
(en)
|
2000-02-11 |
2001-08-16 |
Profile Respiratory Systems Limited |
Drug delivery apparatus
|
|
US8820316B2
(en)
*
|
2000-02-11 |
2014-09-02 |
Respironics Respiratory Drug Delivery (Uk) Ltd |
Drug delivery apparatus
|
|
US8336545B2
(en)
|
2000-05-05 |
2012-12-25 |
Novartis Pharma Ag |
Methods and systems for operating an aerosol generator
|
|
US7971588B2
(en)
|
2000-05-05 |
2011-07-05 |
Novartis Ag |
Methods and systems for operating an aerosol generator
|
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
|
MXPA02001323A
(es)
|
2000-05-10 |
2004-07-16 |
Alliance Pharma |
Microgranulos con base fosfolipida para la liberacion de farmaco.
|
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
|
CA2708703C
(en)
*
|
2000-12-27 |
2012-12-04 |
Alan Bruce Montgomery |
Inhalable aztreonam for treatment and prevention of pulmonary bacterial infections
|
|
US7214364B2
(en)
*
|
2000-12-27 |
2007-05-08 |
Corus Pharma, Inc. |
Inhalable aztreonam lysinate formulation for treatment and prevention of pulmonary bacterial infections
|
|
EP1598059A1
(en)
|
2001-05-18 |
2005-11-23 |
Chiron Corporation |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
|
CA2447600C
(en)
|
2001-05-18 |
2015-10-20 |
Chiron Corporation |
Methods and unit dose formulations for the inhalation administration of aminoglycoside antibiotics
|
|
SI1273292T1
(en)
*
|
2001-07-02 |
2004-12-31 |
Chiesi Farmaceutici S.P.A. |
Optimised formulation of tobramycin for aerosolization
|
|
US20040022740A1
(en)
*
|
2001-07-10 |
2004-02-05 |
Baker William R. |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
US7368102B2
(en)
|
2001-12-19 |
2008-05-06 |
Nektar Therapeutics |
Pulmonary delivery of aminoglycosides
|
|
MEP30108A
(en)
*
|
2002-03-01 |
2010-06-10 |
Chiesi Farmaceutici S P |
Formoterol superfine formulation
|
|
US7334580B2
(en)
*
|
2002-05-07 |
2008-02-26 |
Smaldone Gerald C |
Methods, devices and formulations for targeted endobronchial therapy
|
|
US7607436B2
(en)
*
|
2002-05-06 |
2009-10-27 |
The Research Foundation Of State University Of New York |
Methods, devices and formulations for targeted endobronchial therapy
|
|
AU2003238846A1
(en)
*
|
2002-05-31 |
2003-12-19 |
Childrens Hospital And Regional Medical Center |
Endobronchial delivery of antibiotic in individuals with impaired lung tissue or lung function
|
|
US6966649B2
(en)
*
|
2002-08-12 |
2005-11-22 |
John H Shadduck |
Adaptive optic lens system and method of use
|
|
US20040045546A1
(en)
*
|
2002-09-05 |
2004-03-11 |
Peirce Management, Llc |
Pharmaceutical delivery system for oral inhalation through nebulization consisting of inert substrate impregnated with substance (S) to be solubilized or suspended prior to use
|
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
|
US7718189B2
(en)
*
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
|
WO2005037256A2
(de)
*
|
2003-10-15 |
2005-04-28 |
Pari Gmbh |
Flüssige zubereitung enthaltend tobramycin
|
|
BRPI0509026A
(pt)
|
2004-05-17 |
2007-09-18 |
Corus Pharma Inc |
formulação de aerossol, método para a prevenção e tratamento de infecção causada por bactéria do trato respiratório, e, solução
|
|
JP2008503500A
(ja)
*
|
2004-06-18 |
2008-02-07 |
ノバルティス ヴァクシンズ アンド ダイアグノスティクス， インコーポレイテッド |
気管支感染症の治療法
|
|
US20060073173A1
(en)
*
|
2004-10-04 |
2006-04-06 |
Maria Banach |
Large-scale manufacturing process for the production of pharmaceutical compositions
|
|
US7838532B2
(en)
*
|
2005-05-18 |
2010-11-23 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
US8524735B2
(en)
*
|
2005-05-18 |
2013-09-03 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
AU2013206401B2
(en)
*
|
2005-09-29 |
2016-06-23 |
Novartis Ag |
Antibiotic formulations, unit doses, kits, and methods
|
|
KR101424518B1
(ko)
*
|
2005-09-29 |
2014-08-06 |
노바르티스 아게 |
항생제 제형, 단위 투여체, 키트 및 방법
|
|
CA2838111C
(en)
|
2005-12-08 |
2016-01-19 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections and methods of use thereof
|
|
WO2007070875A1
(en)
*
|
2005-12-15 |
2007-06-21 |
Aerosol Science Laboratories, Inc. |
Treatment of active infections and related compositions
|
|
JP5600432B2
(ja)
*
|
2006-04-06 |
2014-10-01 |
インスメッド， インコーポレイテッド |
コアセルベート化誘導リポソーム被包法及びその調合物
|
|
WO2008013589A2
(en)
*
|
2006-04-24 |
2008-01-31 |
Gloucester Pharmaceuticals |
Treatment of ras-expressing tumors
|
|
US20070286817A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via a swirler delivery
|
|
PE20080329A1
(es)
*
|
2006-06-07 |
2008-04-09 |
Wyeth Corp |
Tratamiento de fibrosis cistica con antibioticos por via de una droga en aerosol
|
|
PE20080712A1
(es)
*
|
2006-06-07 |
2008-05-22 |
Wyeth Corp |
Tratamiento de fibrosis cistica con antibioticos por via de suministro de un torbellinador
|
|
US20070286818A1
(en)
*
|
2006-06-07 |
2007-12-13 |
Wyeth |
Treating cystic fibrosis with antibiotics via an aerosol drug
|
|
US8957027B2
(en)
*
|
2006-06-08 |
2015-02-17 |
Celgene Corporation |
Deacetylase inhibitor therapy
|
|
EP2061772A4
(en)
|
2006-09-11 |
2011-06-29 |
Curis Inc |
MULTIFUNCTIONAL SMALL MOLECULES AS PROLIFERATION-ACTIVE ACTIVE SUBSTANCES
|
|
AU2007297691B2
(en)
*
|
2006-09-19 |
2013-12-19 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations and methods for promoting mucus clearance
|
|
JP2008199905A
(ja)
*
|
2007-02-16 |
2008-09-04 |
Snow Brand Milk Prod Co Ltd |
乳酸菌生残性向上剤
|
|
US20100196455A1
(en)
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
|
JP2010540526A
(ja)
*
|
2007-09-25 |
2010-12-24 |
ノバルティス アーゲー |
エアロゾル化されたバンコマイシンのような薬剤での肺障害の処置
|
|
BRPI0913021A2
(pt)
*
|
2008-05-15 |
2015-10-13 |
Novartis Ag |
distribuição pulmonar de uma fluoroquinolona
|
|
JP2012505222A
(ja)
|
2008-10-07 |
2012-03-01 |
エムペックス・ファーマシューティカルズ・インコーポレーテッド |
肺炎症を低減するためのレボフロキサシンの吸入
|
|
PL2344129T3
(pl)
|
2008-10-07 |
2018-07-31 |
Horizon Orphan Llc |
Formulacje fluorochinolonu w aerozolu dla poprawy właściwości farmakokinetycznych
|
|
MY160130A
(en)
|
2009-02-27 |
2017-02-28 |
Enanta Pharm Inc |
Hepatitis c virus inhibitors
|
|
WO2010105991A1
(en)
*
|
2009-03-20 |
2010-09-23 |
Livia Tiba |
Method of creating salt aerosol for breathing by nebulizing an aqueous saline solution
|
|
DK2445502T4
(da)
|
2009-06-25 |
2022-11-28 |
Alkermes Pharma Ireland Ltd |
Heterocycliske forbindelser til behandling af neurologiske og psykologiske lidelser
|
|
ES2739979T3
(es)
|
2009-09-04 |
2020-02-05 |
Horizon Orphan Llc |
Uso de levofloxacino en aerosol para el tratamiento de la fibrosis quística
|
|
MX2012006799A
(es)
|
2009-12-14 |
2012-07-23 |
Chiesi Farma Spa |
Microparticulas de antibiotico para inhalacion.
|
|
JP6076740B2
(ja)
|
2010-01-07 |
2017-02-08 |
アルカーメス ファーマ アイルランド リミテッド |
第四級アンモニウム塩プロドラッグ
|
|
EP2388008A1
(en)
|
2010-05-14 |
2011-11-23 |
Combino Pharm, S.L. |
Stable, preservative-free, aqueous formulation for the administration by aerosolization comprising tobramycin
|
|
AU2011270701B2
(en)
|
2010-06-24 |
2015-05-14 |
Alkermes Pharma Ireland Limited |
Prodrugs of NH-acidic compounds: ester, carbonate, carbamate and phosphonate derivatives
|
|
AU2011278693B2
(en)
|
2010-07-12 |
2015-02-19 |
Xellia Pharmaceuticals Aps |
Treatment of lung infections by administration of Tobramycin by aerolisation
|
|
AU2011348085B2
(en)
|
2010-12-23 |
2016-12-08 |
Alkermes Pharma Ireland Limited |
Multi- API loading prodrugs
|
|
TWI574687B
(zh)
|
2011-01-03 |
2017-03-21 |
古利斯股份有限公司 |
具有鋅結合部份之刺蝟拮抗劑
|
|
SG10201602569RA
(en)
|
2011-04-01 |
2016-05-30 |
Curis Inc |
Phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
US8826904B2
(en)
|
2011-07-12 |
2014-09-09 |
Cardeas Pharma Corporation |
Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis
|
|
KR20140025534A
(ko)
|
2011-07-12 |
2014-03-04 |
카르데아스 파마 인코퍼레이티드 |
아미카신과 포스포마이신 조합물의 제형 및 인공호흡기 관련 폐렴(vap)과 인공호흡기 관련 기도(vat) 기관지염의 치료 방법 및 시스템
|
|
PL2567691T3
(pl)
|
2011-09-12 |
2015-05-29 |
Meiji Seika Pharma Co Ltd |
Kompozycje wodne obejmujące arbekacynę
|
|
JP5952912B2
(ja)
|
2011-12-15 |
2016-07-13 |
アルカーメス ファーマ アイルランド リミテッド |
二級アミン化合物のプロドラッグ
|
|
CA2858808C
(en)
|
2011-12-15 |
2017-04-18 |
Alkermes Pharma Ireland Limited |
Samidorphan (alks 33) in combination with opioid agonists
|
|
GB201208080D0
(en)
*
|
2012-05-09 |
2012-06-20 |
Norton Healthcare Ltd |
Tobramycin formulation
|
|
KR102277921B1
(ko)
|
2012-05-21 |
2021-07-14 |
인스메드 인코포레이티드 |
폐 감염을 치료하기 위한 시스템
|
|
CN102949379B
(zh)
*
|
2012-11-14 |
2014-11-05 |
中山大学 |
硫酸奈替米星吸入粉雾剂及其制备方法
|
|
EP3581186A1
(en)
|
2012-11-29 |
2019-12-18 |
Insmed Incorporated |
Stabilized vancomycin formulations
|
|
US20140371238A1
(en)
|
2013-03-13 |
2014-12-18 |
Flatley Discovery Lab |
Compounds and methods for the treatment of cystic fibrosis
|
|
SG10201808565QA
(en)
|
2014-03-31 |
2018-11-29 |
Debiopharm Int Sa |
Fgfr fusions
|
|
PL3142643T3
(pl)
|
2014-05-15 |
2019-12-31 |
Insmed Incorporated |
Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
|
|
EP4112071A1
(en)
|
2014-08-26 |
2023-01-04 |
HSF Pharmaceuticals |
Novel immunization agents and methods of use
|
|
ES2971157T3
(es)
|
2014-10-06 |
2024-06-03 |
Apm Therapeutics 1 Inc |
Compuestos de triazolopiridina y métodos para el tratamiento de la fibrosis quística
|
|
US11291780B2
(en)
*
|
2014-12-04 |
2022-04-05 |
Vyaire Medical Consumables Llc |
Breath-actuated nebulizer for medicine inhalation
|
|
CN105616345B
(zh)
*
|
2016-03-01 |
2018-08-21 |
上海方予健康医药科技有限公司 |
一种妥布霉素吸入组合物及其制备方法和用途
|
|
EP3426245B1
(en)
|
2016-03-07 |
2022-12-14 |
Enanta Pharmaceuticals, Inc. |
Hepatitis b antiviral agents
|
|
US11597708B2
(en)
|
2016-09-16 |
2023-03-07 |
Hsf Pharmaceuticals Sa |
Inhibitors of heat shock factors and uses thereof
|
|
EP3688184A1
(en)
*
|
2017-09-29 |
2020-08-05 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Methods for predicting the risk of developing pulmonary colonization/infection bypseudomonas aeruginosa
|
|
WO2019170871A1
(en)
|
2018-03-08 |
2019-09-12 |
Hsf Pharmaceuticals |
Localized activation of virus replication boosts herpesvirus-vectored vaccines
|
|
EP3773505A4
(en)
|
2018-03-30 |
2021-12-22 |
Insmed Incorporated |
PROCESS FOR THE CONTINUOUS MANUFACTURING OF LIPOSOMAL MEDICINAL PRODUCTS
|
|
AU2019267011A1
(en)
|
2018-05-10 |
2020-10-29 |
Cis Pharma Ag |
Biocompatible copolymer containing multiple active agent molecules
|
|
US11234986B2
(en)
|
2018-09-11 |
2022-02-01 |
Curis, Inc. |
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc binding moiety
|
|
CN112955142A
(zh)
|
2018-09-21 |
2021-06-11 |
英安塔制药有限公司 |
官能化杂环化合物作为抗病毒剂
|
|
EP3653716A1
(en)
|
2018-11-19 |
2020-05-20 |
HSF Pharmaceuticals |
Replication-competent controlled alpha-herpesvirus virus vectors and uses therefore
|
|
GB2565941A
(en)
*
|
2018-11-27 |
2019-02-27 |
Norton Healthcare Ltd |
A process for preparing a formulation
|
|
BR112022008235A2
(pt)
|
2019-10-30 |
2022-07-12 |
Cis Pharma Ag |
Portadores de fármacos poliméricos biocompatíveis para a liberação de agentes ativos
|
|
CN115003296A
(zh)
|
2019-12-05 |
2022-09-02 |
弗拉特利发现实验室有限责任公司 |
用于治疗囊肿状纤维化的化合物及其治疗方法
|
|
WO2021214279A1
(en)
|
2020-04-24 |
2021-10-28 |
Hsf Pharmaceuticals |
Replication-competent controlled herpesviruses expressing a sars cov-2 antigen
|
|
US20230233514A1
(en)
|
2020-06-23 |
2023-07-27 |
Flagship Pioneering, Inc. |
Antiviral compounds and methods of using the same
|
|
ES2936277R1
(es)
|
2020-07-20 |
2023-04-18 |
Enanta Pharm Inc |
Peptidos funcionalizados como agentes antivirales
|
|
CA3173333A1
(en)
|
2020-11-23 |
2022-05-27 |
Enanta Pharmaceuticals, Inc. |
Novel spiropyrrolidine derived antiviral agents
|
|
WO2023006993A1
(en)
|
2021-07-30 |
2023-02-02 |
Atmosr |
Fused amino pyridine or pyrimidine derivatives for the treatment of congenital central hypoventilation syndrome
|
|
CN114177140A
(zh)
*
|
2021-12-10 |
2022-03-15 |
卓和药业集团股份有限公司 |
一种硫酸奈替米星气雾剂
|